José Antonio
Rodríguez García

Investigador Senior

Foto de José Antonio

Foto de J.

J.
Solé Violán

J. Solé Violán-rekin lankidetzan egindako argitalpenak (7)

2019

High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients
BMC neurology, Vol. 19, Núm. 1, pp. 167
Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients
Journal of Critical Care, Vol. 51, pp. 117-121

2015

Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction
BMC Neurology, Vol. 15, Núm. 1

2014

Association between serum tissue inhibitor of matrix metalloproteinase-1 levels and mortality in patients with severe brain trauma injury
PLoS ONE, Vol. 9, Núm. 4

2013

The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis
Critical Care, Vol. 17, Núm. 3

2011

Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis
Critical Care, Vol. 15, Núm. 2

2009

Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis
Critical Care, Vol. 13, Núm. 5